Please login to the form below

Not currently logged in
Email:
Password:

Antibody testing

This page shows the latest Antibody testing news and features for those working in and with pharma, biotech and healthcare.

GSK partners with iTeos Therapeutics on next-gen immuno-oncology drug

GSK partners with iTeos Therapeutics on next-gen immuno-oncology drug

British drug-maker will pay $625m upfront for access to iTeos' anti-TIGIT monoclonal antibody. ... GlaxoSmithKline (GSK) has paid iTeos Therapeutics $625m upfront to co-develop and co-commercialise EOS-448 – an anti-TGIT monoclonal antibody (mAb) in

Latest news

  • PHE study finds people who have had COVID-19 can still transmit the virus PHE study finds people who have had COVID-19 can still transmit the virus

    The SIREN study has been regularly performing antibody and PCR testing on healthcare workers from 102 NHS trusts since June 2020. ... The study found that antibody protection after infection lasts for at least five months on average, although the

  • Eli Lilly’s COVID-19 antibody trial paused due to safety issue Eli Lilly’s COVID-19 antibody trial paused due to safety issue

    Lilly is also testing the antibody treatment as a preventative therapy for nursing home residents and workers who may have been exposed to the virus. ... Lilly has since confirmed the OAI notice but said that the data deletions were unrelated to the COVID

  • Britain ramps up COVID-19 testing to track spread of infections Britain ramps up COVID-19 testing to track spread of infections

    Regular testing will increase from 28, 000 people per fortnight to 150, 000 by October. ... restrictions. The survey, co-led by the ONS and The University of Oxford, will use routine swabbing and antibody testing to provide key insights into the rate of

  • Speed kills Speed kills

    From testing to reopening to vetting scientific articles, we have lost track of time. ... Diagnostic and antibody testing has not been excluded from this obsession with velocity either.

  • Delivering safe and effective clinical trials during the COVID-19 pandemic Delivering safe and effective clinical trials during the COVID-19 pandemic

    Secondly, we used antibody testing to establish whether there had already been mild infections; none were detected. ... This ensures that we do not miss asymptomatic infections. We have implemented accurate antibody testing (RAPG-COV-019) that indicates

More from news
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    AbbVie is testing its anti-tau antibody ABBV-8E12 in a phase 2 trial, while Biogen has links to two midphase tau programmes. ... The big biotech is testing its own BIIB092 in early Alzheimer’s patients and has an option to develop an Ionis

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....